BE802126A - Antigene associe au cancer, et procede pour sa preparation et son utilisation - Google Patents

Antigene associe au cancer, et procede pour sa preparation et son utilisation

Info

Publication number
BE802126A
BE802126A BE133300A BE133300A BE802126A BE 802126 A BE802126 A BE 802126A BE 133300 A BE133300 A BE 133300A BE 133300 A BE133300 A BE 133300A BE 802126 A BE802126 A BE 802126A
Authority
BE
Belgium
Prior art keywords
cancer
preparation
antigen associated
antigen
Prior art date
Application number
BE133300A
Other languages
English (en)
Original Assignee
Bjorklund Knut B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjorklund Knut B filed Critical Bjorklund Knut B
Publication of BE802126A publication Critical patent/BE802126A/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BE133300A 1972-07-10 1973-07-10 Antigene associe au cancer, et procede pour sa preparation et son utilisation BE802126A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27027372A 1972-07-10 1972-07-10

Publications (1)

Publication Number Publication Date
BE802126A true BE802126A (fr) 1973-11-05

Family

ID=23030635

Family Applications (1)

Application Number Title Priority Date Filing Date
BE133300A BE802126A (fr) 1972-07-10 1973-07-10 Antigene associe au cancer, et procede pour sa preparation et son utilisation

Country Status (22)

Country Link
JP (2) JPS5817168B2 (fr)
AR (1) AR197243A1 (fr)
AT (1) AT336780B (fr)
BE (1) BE802126A (fr)
BR (1) BR7305142D0 (fr)
CA (1) CA1039650A (fr)
CH (1) CH617853A5 (fr)
DD (2) DD118946A5 (fr)
DE (2) DE2333740C2 (fr)
DK (1) DK139898B (fr)
ES (1) ES416726A1 (fr)
FI (1) FI60567C (fr)
FR (1) FR2191885B1 (fr)
GB (2) GB1443053A (fr)
IL (1) IL42594A (fr)
IN (1) IN138903B (fr)
IT (1) IT1009527B (fr)
NL (1) NL7309257A (fr)
NO (1) NO146338C (fr)
SE (3) SE440697B (fr)
SU (1) SU581842A3 (fr)
ZA (1) ZA734632B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
EP0087898A1 (fr) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Anticorps et antigènes pour le diagnostic et le traitement du cancer

Also Published As

Publication number Publication date
DE2333740A1 (de) 1974-01-31
ZA734632B (en) 1974-06-26
CH617853A5 (en) 1980-06-30
NL7309257A (fr) 1974-01-14
GB1443054A (en) 1976-07-21
IN138903B (fr) 1976-04-10
ES416726A1 (es) 1976-06-16
FR2191885A1 (fr) 1974-02-08
IL42594A (en) 1976-08-31
DD113918A5 (fr) 1975-07-05
JPS56115954A (en) 1981-09-11
DE2366609C2 (fr) 1988-02-25
SE440597B (sv) 1985-08-12
JPS5817168B2 (ja) 1983-04-05
DD118946A5 (fr) 1976-03-20
FR2191885B1 (fr) 1977-07-01
AU5728673A (en) 1975-01-09
BR7305142D0 (pt) 1974-08-22
JPS6018011B2 (ja) 1985-05-08
SE418186B (sv) 1981-05-11
SU581842A3 (ru) 1977-11-25
SE7609836L (sv) 1976-09-06
IL42594A0 (en) 1973-08-29
IT1009527B (it) 1976-12-20
DE2333740C2 (de) 1987-01-22
GB1443053A (en) 1976-07-21
NO146338C (no) 1982-09-08
DK139898B (da) 1979-05-14
JPS4955823A (fr) 1974-05-30
SE7609837L (sv) 1976-09-06
FI60567C (fi) 1982-02-10
AT336780B (de) 1977-05-25
FI60567B (fi) 1981-10-30
NO146338B (no) 1982-06-01
AR197243A1 (es) 1974-03-22
SE440697B (sv) 1985-08-12
CA1039650A (fr) 1978-10-03
ATA600773A (de) 1976-09-15
DK139898C (fr) 1979-10-08

Similar Documents

Publication Publication Date Title
BE767800A (fr) Antigene carcinoembryonaire
CH558171A (de) Tampons auriculaires.
DK128050B (da) Kunstig sene.
SE380901B (sv) Automatisk vetskeanalysapparat, serskilt blodanalysapparat
CA962594A (en) Labeled antibody reagent
CH553405A (fr) Detecteur polarographique.
IT998033B (it) Antigene carcinoembrionale
BE799542A (fr) Cholesterol-oxydase et son procede de preparation,
BE776958R (fr) Tetra-oxo-1,2-dipiperazino-alcanes et procede pour leur
CH546191A (de) Foerderanlage.
NL156067B (nl) Monsterhouder.
BE777305A (fr) Procede de preparation de la pyrocatechine et de ses monoethers
AT326249B (de) Wasch-, spül- und reinigungsmittel
BE802126A (fr) Antigene associe au cancer, et procede pour sa preparation et son utilisation
BE788240A (fr) Teintures, leur procede de preparation et leur application
SE397430B (sv) Magnetiskt paverkbar, forseson s
CH546571A (fr) Tampon mit einfuehreinrichtung.
BE802328A (fr) Cyanophenoxyacetonitriles, leur procede de preparation et leur utilisation
BE794917A (fr) Alpha-2,9-difluoroquinacridone et sa preparation
CH557016A (de) Heizbare galette.
NL7410138A (nl) Werkwijze ter bereiding van 2-alkylideen 3-alkynalen, 2-alkylideen 3-alkanalen en acetalen daarvan.
CH556782A (de) Schleppkreisfoerderer.
IT954090B (it) Procedimento per produrre anticorpi
NL151954B (nl) Fluidumafgifteinrichting.
BE786842A (fr) Colorant azoique, sa preparation et ses utilisations

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: A.B. BONNIERFORETAGEN

Effective date: 19930710